MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive income (loss)
-$9,054K
(-248.13%↓ Y/Y)
Net income (loss)
-$9,054K
(-248.13%↓ Y/Y)
Auryxia
$36,190K
Vafseo
$15,802K
Japan Tobacco
Incorporation And Torii...
$1,179K
Tanabe Pharma
Corporation
$341K
MEDICEArzneimittel Putter Gmb HCo KG
$32K
Income (loss) before
income taxes
-$8,928K
(-246.07%↓ Y/Y)
Income tax expense
$126K
Change in fair value of
warrant liability
-$456K
(-194.19%↓ Y/Y)
Other income
$3K
(-98.59%↓ Y/Y)
Product
$51,992K
License Collaboration
And Other Revenue
$1,552K
Income (gain) from
operations
-$4,696K
(-134.75%↓ Y/Y)
Interest expense
-$4,691K
(39.63%↑ Y/Y)
Total revenues
$53,544K
(-6.61%↓ Y/Y)
Total operating
expenses
$45,950K
(26.94%↑ Y/Y)
Total cost of goods
sold
$12,290K
(61.18%↑ Y/Y)
Selling, general and
administrative
$30,436K
(18.23%↑ Y/Y)
Research and development
$14,807K
(51.80%↑ Y/Y)
License
$707K
(0.86%↑ Y/Y)
Cost of product and
other revenue
$12,290K
(61.18%↑ Y/Y)
Back
Back
Income Statement
Akebia Therapeutics, Inc. (AKBA)
Akebia Therapeutics, Inc. (AKBA)
source: myfinsight.com